Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • S152: COMBINATORY THERAPY OF A...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL

Bibliographic Details
Published in:HemaSphere
Main Authors: Nikola Čuřík, Adam Laznicka, Vaclava Polivkova, Jitka Křížková, Pavel Semerak, Eva Pokorna, Pavla Suchankova, Pavel Burda, Andreas Hochhaus, Kateřina Machová Poláková
Format: Article
Language:English
Published: Wiley 2023-08-01
Online Access:http://journals.lww.com/10.1097/01.HS9.0000967520.71557.f0
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://journals.lww.com/10.1097/01.HS9.0000967520.71557.f0

Similar Items

  • Imatinib therapy of chronic myeloid leukemia significantly reduces carnitine cell intake, resulting in adverse events
    by: Pavel Burda, et al.
    Published: (2024-10-01)
  • Asciminib in late-line CML treatment
    by: Kendra Sweet, et al.
    Published: (2025-08-01)
  • S154: IMATINIB-RESISTANT CLONES ISOLATED FROM A MODEL OF BLAST CRISIS OF CHRONIC MYELOID LEUKAEMIA DIFFER IN MUTATIONS IN BCR::ABL1 AND OTHER CANCER RELATED GENES AND IN THEIR SENSITIVITY TO BH3-MIMETICS
    by: A. Laznicka, et al.
    Published: (2022-06-01)
  • P706: ASCIMINIB USE IN CML: THE UK EXPERIENCE
    by: A. Innes, et al.
    Published: (2022-06-01)
  • P209 | COMBINATION OF PONATINIB AND ASCIMINIB IN PATIENTS WITH ADVANCED CHRONIC MYELOID LEUKEMIA
    by: G. Cotilli, et al.
    Published: (2025-09-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs